Health Services Research
Latest posts by Health Services Research (see all)
- Higher Medicare SNF Care Utilization by Dual-Eligible Beneficiaries: Can Medicaid Long-Term… - Jul. 22, 2014
- Factors Affecting Receipt of Expensive Cancer Treatments and Mortality: Evidence from Stem Cell… - Jul. 22, 2014
- Effect of Massachusetts Health Reform on Chronic Disease Outcomes - Jul. 16, 2014
- Surge Capacity: Analysis of Census Fluctuations to Estimate the Number of Intensive Care Unit… - Jul. 15, 2014
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.